You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › November › 04
Pfizer
8 months ago
Two groups fight for edge in one of the most lucrative drug classes in pharmaceutical industry history
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer ○
The clash reflects the shifting landscape for weight loss and diabetes drugs, with Novo Nordisk trailing Eli Lilly as companies like Pfizer race to break in.
Pfizer and Novo Nordisk sweeten offers for Metsera as bidding war intensifies ○
Improved pitches from both large pharma groups expected to be revealed later on Tuesday
Pfizer tops estimates, raises profit guidance even as sales fall ⊕⊕
Pfizer hiked its full-year profit guidance, citing its strong business performance and cost cuts, even as sales for the period fell.
page 1 of 1